This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Renuka Sivendran
Director, Analytical Development at Five Prime Therapeutics


Renuka Sivendran is the Director of the Analytical Development Group at Five Prime Therapeutics. Prior to Five Prime, she held different roles at Amgen, including Similarity Leader for the adalimumab and infliximab biosimilar programs and Drug Product Team Leader for the panitumumab and erenumab programs. Prior to Amgen, she worked at Regeneron Pharmaceuticals as a Scientist in the Formulation Development and Protein Chemistry Groups.  She obtained her bachelor’s degree in chemistry from the Millersville University of Pennsylvania, her Ph.D. in biophysics from the University of Massachusetts, and she did her postdoctoral fellowship at the National Cancer Institute at the NIH.

Agenda Sessions

  • Setting Release Specifications to Ensure Product Quality